Related Experiment Video
Updated: May 22, 2026

10:47
Quantification of Proliferative and Dead Cells in Enteroids
Published on: January 31, 2020
Clear cells are associated with proliferative activity in ependymoma: a quantitative study
Keisuke Ishizawa1, Takashi Komori, Yasuo Aihara
1Department of Pathology, Saitama Medical University, Saitama 350-0495, Japan. ishizawa@saitama-med.ac.jp
Clinical Neuropathology
|May 4, 2012
Summary
Clear cells in ependymomas correlate with higher proliferative activity, suggesting they are an independent prognostic factor beyond WHO grade. Assessing clear cells is crucial for accurate ependymoma diagnosis.
Area of Science:
- Neuro-oncology
- Tumor pathology
- Cancer biology
Background:
- Ependymomas are classified as WHO Grade II or III (anaplastic).
- Clear cell ependymoma (WHO Grade III) features clear cell proliferation, but clear cells also appear in conventional ependymomas.
- The prognostic significance of clear cells in ependymomas requires further elucidation.
Purpose of the Study:
- To investigate the direct relationship between the presence of clear cells and proliferative activity in ependymomas.
- To determine if clear cells are an independent prognostic factor in ependymoma diagnosis.
Main Methods:
- Studied 14 ependymomas (6 Grade II, 8 Grade III) containing clear cells.
- Utilized hematoxylin and eosin (H&E) staining, PHH3 (mitosis marker), and MIB-1 (Ki-67 antibody) immunostaining.
- Assessed necrosis, microvascular proliferation, clear cell grade (I-III), mitotic counts, and MIB-1 index.
Main Results:
- Necrosis and microvascular proliferation were observed regardless of clear cell grade.
- A higher abundance of clear cells was significantly associated with increased proliferative activity (mitotic count and MIB-1 index).
Conclusions:
- Clear cells in ependymomas are linked to higher proliferative activity.
- Clear cells may serve as an independent prognostic factor, distinct from WHO grade, necrosis, or microvascular proliferation.
- Evaluating clear cells is important for ependymoma diagnosis, irrespective of the 'clear cell ependymoma' subtype.
